Loading...
Market
Ethical controversy over OpenCRISPR by 2025?
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Major news outlets and bioethics publications.
Story
ProfluentBio Launches OpenCRISPR: AI-Generated Gene Editor with Modest Impact
Apr 23, 2024, 01:49 AM
ProfluentBio has announced the launch of OpenCRISPR, a groundbreaking open-source AI-generated gene editor. Developed using ProfluentBio's large language models, this tool includes a Cas9-like protein and guide RNA, designed to edit human DNA with modest on-target activity. The initiative, which aims to democratize access to gene editing technology, has the potential to revolutionize biomedicine but is not expected to impact clinical editing in the next 3 years. The sequences and molecules designed by AI have been freely released under the OpenCRISPR initiative, marking a significant milestone in personalized medicine.
View original story
Similar markets
Low (0-10 institutions) • 25%
Moderate (11-30 institutions) • 25%
High (31-50 institutions) • 25%
Very High (over 50 institutions) • 25%
Yes • 50%
No • 50%
Broad support for continuation • 33%
Mixed reactions • 34%
Broad criticism leading to halt • 33%
0-5 • 25%
6-10 • 25%
11-20 • 25%
More than 20 • 25%
